SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-124403
Filing Date
2020-11-12
Accepted
2020-11-12 16:11:23
Documents
43
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029525-1_10q.htm 10-Q 355103
2 EXHIBIT 31 tm2029525d1_ex31.htm EX-31 8595
3 EXHIBIT 32 tm2029525d1_ex32.htm EX-32 4129
  Complete submission text file 0001104659-20-124403.txt   1775391

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bpth-20200930.xml EX-101.INS 231423
5 XBRL TAXONOMY EXTENSION SCHEMA bpth-20200930.xsd EX-101.SCH 26526
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bpth-20200930_cal.xml EX-101.CAL 20659
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bpth-20200930_def.xml EX-101.DEF 54195
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpth-20200930_lab.xml EX-101.LAB 179535
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpth-20200930_pre.xml EX-101.PRE 147713
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 201306777
SIC: 2834 Pharmaceutical Preparations